via The Scientist RSS https://ift.tt/wQKmHAT A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous. https://ift.tt/im8SJsV November 29, 2022 at 03:14AM